1. Heaps JM, Nieberg RK, Berek JS. Malignant neoplasms arising in endometriosis. Obstet Gynecol. 1990. 75:1023–1028.
Article
2. Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol. 1997. 176:572–579.
Article
3. Bergqvist A, Rannevik G, Thorell J. Estrogen and progesterone cytosol receptor concentration in endometriotic tissue and intrauterine endometrium. Acta Obstet Gynecol Scand Suppl. 1981. 101:53–58.
Article
4. Gould SF, Shannon JM, Cunha GR. Nuclear estrogen binding sites in human endometriosis. Fertil Steril. 1983. 39:520–524.
Article
5. Mostoufizadeh M, Scully RE. Malignant tumors arising in endometriosis. Clin Obstet Gynecol. 1980. 23:951–963.
Article
6. Jones KD, Owen E, Berresford A, Sutton C. Endometrial adenocarcinoma arising from endometriosis of the rectosigmoid colon. Gynecol Oncol. 2002. 86:220–222.
Article
7. Kurman RJ, Craig JM. Endometrioid and clear cell carcinoma of the ovary. Cancer. 1972. 29:1653–1664.
Article
8. Veiga-Ferreira MM, Leiman G, Dunbar F, Margolius KA. Cervical endometriosis: facilitated diagnosis by fine needle aspiration cytologic testing. Am J Obstet Gynecol. 1987. 157(4 Pt 1):849–856.
Article
9. Ismail SM. Cone biopsy causes cervical endometriosis and tuboendometrioid metaplasia. Histopathology. 1991. 18:107–114.
Article
10. Baker PM, Clement PB, Bell DA, Young RH. Superficial endometriosis of the uterine cervix: a report of 20 cases of a process that may be confused with endocervical glandular dysplasia or adenocarcinoma in situ. Int J Gynecol Pathol. 1999. 18:198–205.
11. Hanau CA, Begley N, Bibbo M. Cervical endometriosis: a potential pitfall in the evaluation of glandular cells in cervical smears. Diagn Cytopathol. 1997. 16:274–280.
Article
12. Nishida M, Watanabe K, Sato N, Ichikawa Y. Malignant transformation of ovarian endometriosis. Gynecol Obstet Invest. 2000. 50:Suppl 1. 18–25.
Article
13. Brooks JJ, Wheeler JE. Malignancy arising in extragonadal endometriosis: a case report and summary of the world literature. Cancer. 1977. 40:3065–3073.
14. Leiserowitz GS, Gumbs JL, Oi R, Dalrymple JL, Smith LH, Ryu J, Scudder S, Russell AH. Endometriosis-related malignancies. Int J Gynecol Cancer. 2003. 13:466–471.
Article
15. Modesitt SC, Tortolero-Luna G, Robinson JB, Gershenson DM, Wolf JK. Ovarian and extraovarian endometriosis-associated cancer. Obstet Gynecol. 2002. 100:788–795.
Article
16. Sainz de la Cuesta R, Eichhorn JH, Rice LW, Fuller AF Jr, Nikrui N, Goff BA. Histologic transformation of benign endometriosis to early epithelial ovarian cancer. Gynecol Oncol. 1996. 60:238–244.
Article
17. Yantiss RK, Clement PB, Young RH. Neoplastic and pre-neoplastic changes in gastrointestinal endometriosis: a study of 17 cases. Am J Surg Pathol. 2000. 24:513–524.
18. Wheeler JM, Malinak LR. Recurrent endometriosis: incidence, management, and prognosis. Am J Obstet Gynecol. 1983. 146:247–253.
Article
19. Purdie DM, Bain CJ, Siskind VJ, Russell P, Hacker NF, Ward BG, Quinn MA, Green AC. Hormone replacement therapy and risk of epithelial ovarian cancer. Br J Cancer. 1999. 81:559–563.
Article
20. Reimnitz C, Brand E, Nieberg RK, Hacker NF. Malignancy arising in endometriosis associated with unopposed estrogen replacement. Obstet Gynecol. 1998. 71(3 Pt 2):444–447.
21. Cohen I, Altaras MM, Lew S, Tepper R, Beyth Y, Ben-Baruch G. Ovarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during tamoxifen therapy: a case report and review of the literature. Gynecol Oncol. 1994. 55(3 Pt 1):443–447.
Article
22. Bese T, Simsek Y, Bese N, Ilvan S, Arvas M. Extensive pelvic endometriosis with malignant change in tamoxifen-treated postmenopausal women. Int J Gynecol Cancer. 2003. 13:376–380.
Article